share_log

海王生物:关于中国证券监督管理委员会深圳监管局对公司采取责令改正措施决定的整改报告

Haiwang Biotech: Rectification Report on the Decision of the Shenzhen Regulatory Bureau of the China Securities Regulatory Commission to Order Corrective Measures against the Company

SZSI ·  Nov 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more